Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil
- DOI
- 10.1186/s12879-023-08288-8
- Published
- 2023-05-24
- Container
- BMC Infectious Diseases
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12879-023-08288-8,
title = {Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil},
author = {Ricardo Sobhie Diaz and James R. Hunter and Michelle Camargo and Danilo Dias and Juliana Galinskas and Isabela Nassar and Isaac Barbosa de Lima and Debora Bellini Caldeira and Maria Cecilia Sucupira and Mauro Schechter},
year = {2023},
journal = {BMC Infectious Diseases},
doi = {10.1186/s12879-023-08288-8},
url = {https://doi.org/10.1186/s12879-023-08288-8}
}RIS
TY - JOUR TI - Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil AU - Ricardo Sobhie Diaz AU - James R. Hunter AU - Michelle Camargo AU - Danilo Dias AU - Juliana Galinskas AU - Isabela Nassar AU - Isaac Barbosa de Lima AU - Debora Bellini Caldeira AU - Maria Cecilia Sucupira AU - Mauro Schechter PY - 2023 JO - BMC Infectious Diseases DO - 10.1186/s12879-023-08288-8 UR - https://doi.org/10.1186/s12879-023-08288-8 ER -
APA
Diaz, R. S., Hunter, J. R., Camargo, M., Dias, D., Galinskas, J., Nassar, I., Lima, I. B. D., Caldeira, D. B., Sucupira, M. C., & Schechter, M. (2023). Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil. BMC Infectious Diseases. https://doi.org/10.1186/s12879-023-08288-8
Source records
- crossref · retrieved 2026-09-27T04:07:35.486Z